Research the world's first vaccine against the coronavirus on volunteers in Sechenovskiy University successfully finished the first group of volunteers will be discharged on Wednesday, the second - on July 20, said Last news Director of the Institute for translational medicine and biotechnology sechenovskiy University Vadim Tarasov.
before the press service of the Ministry of health reported that on June 18 in Sechenovskiy the University was started the clinical validation of vaccines against coronavirus, which was developed by national research centre of epidemiology and Microbiology named after N. F. Gamalei.
Director of the Institute for medical Parasitology, tropical and vector-borne diseases sechenovskiy University Alexander Lukashev in conversation with Last news said that the purpose of this phase of the study was to demonstrate the safety of the vaccine for human health, and that was done.
The volunteers were divided into two groups - the first received one dose of vaccine, the second - two. In addition to increasing body temperature in the first few days After vaccination, the volunteers there were no adverse reactions, everyone is feeling great, drew attention Lukashev.
for its part Tarasov said that Volunteers for a long period were isolated, had limited contact with the outside world even before the tests to exclude infection with coronavirus.
Prolonged isolation, According to Tarasova, the impact on the psychological state of volunteers in the research process arose a scandal, increased emotional tension, for this reason, work has been joined by psychologists to reduce tension in difficult conditions.
But soon the Volunteers will return to the usual life, can exercise, study, go to the workplace, He said. After discharge, which is expected on fifteen and 20 July, with the state of their health will be determined by observation physicians will appreciate how does their immune system.
Further plan the development of a vaccine is determined by the strategy of the developer, as well as among them the complexity of the epidemiology of the virus and the ability to scale production, explained Lukashev.
Lukashev complements his words by the fact that ezopasnost vaccines against coronavirus infection confirmed in clinical trials.
He said that before the start of clinical trials has conducted a detailed study volunteers, and among them were the lack of antibodies to the coronavirus. Then for two weeks isolated to prevent infection. This was followed by immunization, began research work.
The latest information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.